Plant Phenotyping Market is Projected to Reach $268.1 million by 2023

Apr 7 02:00 2022 MNM Print This Article

The plant phenotyping market is estimated to be USD 158.2 million in 2018 and is projected to reach USD 268.1 million by 2023, at a CAGR of 11.14%. The global market is mainly driven by the growing importance of sustainable crop production among farmers by using improved crop varieties.

The plant phenotyping market is estimated to be USD 158.2 million in 2018 and is projected to reach USD 268.1 million by 2023,Guest Posting at a CAGR of 11.14%. The market growth is driven by factors such as the growing demand for sustainable crop production using improved crop varieties and significant advancements in imaging sensors.

Different types of plant phenotyping equipment include conveyor-based/modular systems, bench-based systems, portable/handheld systems, and drones. Conveyor-based systems are mostly preferred by plant breeders as there is a high demand for high-throughput phenotyping systems. The use of drones is projected to grow in the future as they have high demand in countries with limited manpower and higher ease in the procurement of data.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=236591018

Flexible and extendable computational tools are required to address the diversity of plant phenotyping problems. Thus, the demand for software tools is projected to grow at a higher CAGR during the forecast period as they help to measure and provide reliable data about plant traits in a non-destructive manner through image analysis, data acquisition, and system controls.

This report includes a study of marketing and development strategies, along with the product portfolios of leading companies. It also includes the profiles of key companies such as LemnaTec (Germany), Delta-T Devices (UK), CropDesign - BASF SE (Germany), Heinz Walz (Germany), Phenospex (Netherlands), WPS (Netherlands), Photon Systems Instruments (Czech Republic), Qubit Systems (Canada), KeyGene (Netherlands), Rothamsted Research (UK), The Vienna Biocenter Core Facilities (Austria), and Phenomix (France).

Source: Free Guest Posting Articles from ArticlesFactory.com

About Article Author

MNM
MNM

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

View More Articles